| Financial Year |
September 30 2022 |
| Monetary Funds |
443,666,804.85 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
45,213,221.37 |
| Advances to Suppliers |
53,914,965.66 |
| Other Receivables |
21,805,635.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
311,246,428.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,787,560.78 |
| Total Current Assets |
887,285,445.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
297,437,931.69 |
| Investment Properties |
-- |
| Fixed Assetes |
3,139,452,136.52 |
| Under-construction Projects |
418,584,357.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
523,334,048.49 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
139,072,790.55 |
| R&D expenses |
-- |
| Goodwill |
18,370,870.71 |
| Long-Term Deferred and Prepaid Expenses |
5,436,773.49 |
| Deferred Income Tax Assets |
4,757,077.90 |
| Other Non-Current Assets |
87,820,181.41 |
| Sub-Total of Non-Current Assets |
4,827,279,465.89 |
| Total Assets |
5,714,564,911.87 |
| Short-Term Loans |
1,384,486,803.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
209,559,987.68 |
| Accounts Payable |
343,760,528.38 |
| Accounts Received In Advance |
151,763.07 |
| Employee Compensation Payable |
36,865,089.85 |
| Taxes Payable |
5,770,740.45 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
126,835,439.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
291,448,331.04 |
| Other Current Liabilities |
4,820,942.26 |
| Sub-Total of Current Liabilities |
2,484,600,318.12 |
| Long-term Loans |
205,061,017.38 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
50,378,550.07 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
410,595,641.83 |
| Total Liabilities |
2,895,195,959.95 |
| Paid-In Capital(Or Share Stock) |
992,909,980.00 |
| Capital Surplus |
586,020,444.18 |
| Surplus Reserve |
287,728,801.20 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
901,050,109.94 |
| Minority Stockholder's Interest |
51,659,616.60 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,767,709,335.32 |
| Owner's Equity（Stockholder's Equity） |
2,819,368,951.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,714,564,911.87 |
